4//SEC Filing
Walsh Jeffrey T. 4
Accession 0000950170-24-116065
CIK 0001858848other
Filed
Oct 20, 8:00 PM ET
Accepted
Oct 21, 8:43 PM ET
Size
5.5 KB
Accession
0000950170-24-116065
Insider Transaction Report
Form 4
Walsh Jeffrey T.
Director
Transactions
- Award
Stock Option (Right to buy)
2024-10-18+34,000→ 34,000 totalExercise: $2.04From: 2025-05-31Exp: 2034-10-17→ Common Stock (34,000 underlying)
Footnotes (1)
- [F1]Option granted pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest in full May 31, 2025, or, if earlier, the day immediately before the date of the next annual meeting of stockholders that occurs after the grant date, subject to the Reporting Person continuing to be a service provider to the Issuer through each applicable vesting date.
Documents
Issuer
Tenaya Therapeutics, Inc.
CIK 0001858848
Entity typeother
Related Parties
1- filerCIK 0001578251
Filing Metadata
- Form type
- 4
- Filed
- Oct 20, 8:00 PM ET
- Accepted
- Oct 21, 8:43 PM ET
- Size
- 5.5 KB